Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Pfizer, Starboard Value
Former Pfizer CEO, CFO say they will not be involved in Starboard's campaign against drugmaker
Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio said they will not be involved with activist investor Starboard Value, which reportedly wants the U.S. drug giant to make changes to turn its performance around.
Former Pfizer CEO, finance chief step back from Starboard's activist campaign
The about face comes as the board grapples with the activist's efforts, and just days before Starboard's Jeff Smith was slated to meet with the CEO, sources said.
Pfizer’s Former CEO Won’t Be Involved in Starboard Value Effort
Former Pfizer Inc. executives Ian Read and Frank D’Amelio have decided “not to be involved” in Starboard Value’s activist campaign against the drug company, according to statement released on their behalf late Wednesday.
18h
What's Happening With Pfizer Stock?
Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...
Business Wire
4h
Pfizer Declares Fourth-Quarter 2024 Dividend
Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.42 fourth-quarter 2024 dividend on the ...
MM&M
2d
Activist investor takes $1B stake in Pfizer, aims to turn around company
Citing people familiar with the matter, The Journal reported that Starboard approached former Pfizer CEO Ian Read and CFO ...
1d
on MSN
Pfizer CEO’s Job Is at Risk. A Shot of Discipline Could Help.
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
1d
on MSN
Analysis-GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...
bovnews
12h
The PFE Conundrum: Why Pfizer Inc’s Stock Is Making Headlines Again
On Tuesday, Pfizer Inc (PFE) stock saw a decline, ending the day at $29.18 which represents a decrease of $-0.02 or -0.07% from the prior close of $29.2. The stock opened at $29.21 and touched a low ...
FierceBiotech
1d
'Ongoing challenges' force Pfizer to scrap oral RSV med from ReViral buyout
In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...
1d
on MSN
Pfizer, BioNTech win bid to invalidate CureVac's UK COVID vaccine patents
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Starboard
Stocks
Covid-19
Ian Read
RSV
Feedback